Results 71 to 80 of about 6,173 (250)

Safety of topical corticosteroids in pregnancy (Review) [PDF]

, 2015
Background Topical corticosteroids are the most frequently prescribed dermatological treatment and are often used by pregnant women with skin conditions. However, little is known about their safety in pregnancy.
Altman, Ambros-Rudolph, Anderson, Arosarena, Ballard, Ballard, Baumann, Beitins, Berth-Jones, Bjørn, Bjørn, Briggs, Carmichael, Carmichael, Carmichael, Casey, Chi, Chi, Chi, Chi, Cunningham, Czeizel, Czeizel, Devane, Edwards, Gitau, Gitau, Gur, Guyatt, Hale, Hardy, Hengge, Hviid, Ikegami, Jessop, Katz, Khumalo, Källén, Leachman, Lin, Mahé, Marsland, Meadows, Mehta, Murphy, Murphy, Mygind, Nanda, Narama, Nasjleti, Park-Wyllie, Petersen, Pradat, Rodriguez-Pinilla, Romo, Shah, Sifton, Skuladottir, Skuladottir, Skuladottir, Smith, Stanier, Sun, Turpeinen, Turpeinen, Uno, Walker, Weatherhead, Wong, Yamada, Zandi, Zip   +71 more
core   +1 more source

Intraocular Pressure Changes After Intravitreal Fluocinolone Acetonide Implant: Results from Four European Countries [PDF]

, 2022
none14siIntroduction: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant delivers a continuous intravitreal corticosteroid dose for the treatment of refractory diabetic macular oedema (DMO). The aim of this study was to assess the impact of an
Arnould, Louis, Baillif, Stephanie, Barbosa-Breda, Joao, Bourredjem, Abderrahmane, Busch, Catharina, Creuzot-Garcher, Catherine, Gabrielle, Pierre-Henry, Grise-Dulac, Alice, Hamza, Mahmoud, Lebrize, Sarah, Lupidi, Marco, Mariotti, Cesare, Massin, Pascale, Rehak, Matus   +13 more
core   +2 more sources

Visual function and retinal morphological changes after single suprachoroidal delivery of fluocinolone acetonide (Iluvien®) implant in eyes with chronic diabetic macular edema [PDF]

, 2023
Ehab N. El Rayes, M. Leila
openalex   +1 more source

Efficacy of Botulinum Toxin A for the Management of Melasma: A Split‐Face, Randomized Control Study

Journal of Cosmetic Dermatology, Volume 24, Issue 8, August 2025.
ABSTRACT Background Melasma management remains challenging due to its multifactorial nature pathogenesis and recurrent nature. Previous studies showed positive effects of botulinum toxin A (BoNT‐A) for treating and preventing ultraviolet‐induced hyperpigmentation.
Sasipim Chaijaras, Suphagan Boonpethkaew, Sonphet Chirasuthat, Nawara Sakpuwadol, Tanat Yongpisarn, Pimsiri Anansiripun, Vasanop Vachiramon   +6 more
wiley   +1 more source

Pathogenesis of Melasma Explained

International Journal of Dermatology, Volume 64, Issue 7, Page 1201-1212, July 2025.
Pathophysiology of melasma. ABSTRACT This review provides an in‐depth analysis of the pathophysiology of melasma and highlights recent studies that elucidate its underlying mechanisms. Given the prevalence of melasma, a thorough understanding of its pathogenesis is critical for the development of effective treatment strategies.
Lara Ali, Firas Al Niaimi
wiley   +1 more source

Fluocinolone-acetonide [PDF]

Reactions Weekly, 2020
  +5 more sources

Neuroichthyosis With a De Novo Variant c.494C>T in ELOVL1 and Severe Pruritus Relieved by Dupilumab

Pediatric Dermatology, Volume 42, Issue 4, Page 844-848, July/August 2025.
ABSTRACT We report a patient with neuroichthyosis with an ELOVL1 variant associated with severe pruritus who responded well to dupilumab therapy. Our case is the third known patient reported with this de novo heterozygous dominant variant. The feature of severe progressive pruritus greatly impairing quality of life is unique among these reports.
Danielle Marcoux, Sophie‐Anne Savard, Victor Kokta, Elsa Rossignol, Luis H. Ospina   +4 more
wiley   +1 more source

Comparative blanching activities of some topical corticosteroid containing lotions [PDF]

, 1981
The blanching activities of Betnovate and Celestoderm-V lotions (betamethasone-17-valerate, 0,1%) and Diprosone lotion (betamethasone dipropionate, 0,55%) were determined by measuring their ability to cause blanching of human skin after topical ...
Haigh, J M, Kanfer, I, Meyer, I
core   +1 more source

Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer (2025 Edition)

Cancer Innovation, Volume 4, Issue 3, June 2025.
ABSTRACT Background The phosphoinositide 3‐kinase (PI3K)/protein kinase B (PKB or AKT)/mammalian target of rapamycin (mTOR) signaling pathway (PAM pathway) plays a critical role in breast cancer pathogenesis and progression, and is closely linked with resistance to endocrine therapy in advanced breast cancer.
The Breast Cancer Expert Committee of the National Quality Control Center for Cancer, The Expert Committee on Cancer Prevention and Treatment of the Health China Research Center, The Society of Clinical Research on Oncology Medications of the China Anti‐Cancer Association, The Society of Onco‐Pathology of the China Anti‐Cancer Association   +3 more
wiley   +1 more source

Ophtalmologie. Rétinopathie diabétique: nouvelles possibilités thérapeutiques [Diabetic retinopathy: new therapeutic possibilities]. [PDF]

, 2015
La rétinopathie diabétique touche un nombre croissant de personnes, soit quatre millions en Europe, ce chiffre va probablement doubler d'ici 2030. Si l'on considère que 25-30% de ces patients sont atteints de rétinopathie diabétique, un dépistage et un ...
Behar-Cohen, F., Guex-Crosier, Y.
core